222Indexed trials
Market Rank #18 · Evidence Tier A
Taiwan
Neuroscience Intelligence
Taiwan neuroscience intelligence: 222 indexed trials, 54 institutions, research score 40.66.
50Recruiting
54Research institutions
40.7Research score
Evidence profile
70Sponsors
23Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 40.7 · Data confidence 100.00 · Evidence 40.7
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons48trials
alzheimers32trials
autism30trials
adhd25trials
schizophrenia13trials
epilepsy13trials
stroke11trials
other_neurology9trials
depression8trials
neuromuscular5trials
Leading indexed sponsors
National Taiwan University Hospital50trials
Merck Sharp & Dohme LLC20trials
Chang Gung Memorial Hospital20trials
China Medical University Hospital13trials
Taipei Medical University7trials
Eli Lilly and Company6trials
Hoffmann-La Roche6trials
Tri-Service General Hospital (TSGH)5trials
Novartis Pharmaceuticals4trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials